• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Binding interactions with the complementary subunit of nicotinic receptors.与烟碱型乙酰胆碱受体互补亚基的结合相互作用。
J Biol Chem. 2013 Mar 8;288(10):6991-7. doi: 10.1074/jbc.M112.439968. Epub 2013 Jan 24.
2
Nicotinic pharmacophore: the pyridine N of nicotine and carbonyl of acetylcholine hydrogen bond across a subunit interface to a backbone NH.烟碱药理学基团:尼古丁吡啶氮原子与乙酰胆碱羰基氢原子在亚基界面形成氢键,与骨架 NH 相互作用。
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13206-11. doi: 10.1073/pnas.1007140107. Epub 2010 Jun 28.
3
Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor.利用物理化学方法区分烟碱型乙酰胆碱受体上的烟碱样激动剂和胆碱能激动剂。
J Am Chem Soc. 2005 Jan 12;127(1):350-6. doi: 10.1021/ja0461771.
4
Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.结构与功能研究调节剂 NS9283 揭示激动剂样作用机制在 α4β2 烟碱型乙酰胆碱受体。
J Biol Chem. 2014 Sep 5;289(36):24911-21. doi: 10.1074/jbc.M114.568097. Epub 2014 Jun 30.
5
Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligand-bound α2 homopentamer.人神经元烟碱型乙酰胆碱受体细胞外结构域五聚体组装体的晶体结构:配体结合的α2同五聚体
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9635-40. doi: 10.1073/pnas.1602619113. Epub 2016 Aug 4.
6
Role in the selectivity of neonicotinoids of insect-specific basic residues in loop D of the nicotinic acetylcholine receptor agonist binding site.昆虫特异性碱性残基在烟碱型乙酰胆碱受体激动剂结合位点的环D中对新烟碱类药物选择性的作用。
Mol Pharmacol. 2006 Oct;70(4):1255-63. doi: 10.1124/mol.106.026815. Epub 2006 Jul 25.
7
Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors.罕见的人类烟碱型乙酰胆碱受体α4 亚基(CHRNA4)变体影响高亲和力烟碱型乙酰胆碱受体的表达和功能。
J Pharmacol Exp Ther. 2014 Mar;348(3):410-20. doi: 10.1124/jpet.113.209767. Epub 2014 Jan 2.
8
Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.工程化α4β2烟碱型乙酰胆碱受体作为测量激动剂在正构低亲和力α4-α4界面处结合和效应的模型。
Neuropharmacology. 2015 May;92:135-45. doi: 10.1016/j.neuropharm.2014.12.035. Epub 2015 Jan 13.
9
Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.通过选择性破坏α4亚基M3-M4胞质环中的共有位点来构建对尼古丁敏感性降低或增加的α4β2烟碱型乙酰胆碱受体。
Neuropharmacology. 2015 Dec;99:273-84. doi: 10.1016/j.neuropharm.2015.04.022. Epub 2015 May 6.
10
Photoaffinity labeling the agonist binding domain of alpha4beta4 and alpha4beta2 neuronal nicotinic acetylcholine receptors with [(125)I]epibatidine and 5[(125)I]A-85380.用[¹²⁵I]埃博霉素和5-[¹²⁵I]A-85380对α4β4和α4β2神经元烟碱型乙酰胆碱受体的激动剂结合域进行光亲和标记。
Biochim Biophys Acta. 2009 Sep;1788(9):1987-95. doi: 10.1016/j.bbamem.2009.06.012. Epub 2009 Jun 21.

引用本文的文献

1
Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models.VMY-2-95对皮质酮诱导的小鼠损伤及细胞模型的保护作用。
Acta Pharm Sin B. 2021 Jul;11(7):1903-1913. doi: 10.1016/j.apsb.2021.03.002. Epub 2021 Mar 9.
2
Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents.用于预测烟草成分与人烟碱型乙酰胆碱受体α7结合的竞争性对接模型。
Oncotarget. 2018 Feb 8;9(24):16899-16916. doi: 10.18632/oncotarget.24458. eCollection 2018 Mar 30.
3
Secondary Ammonium Agonists Make Dual Cation-π Interactions in α4β2 Nicotinic Receptors.次级铵类激动剂在 α4β2 烟碱型乙酰胆碱受体中形成双重阳离子-π 相互作用。
eNeuro. 2017 Mar 30;4(2). doi: 10.1523/ENEURO.0032-17.2017. eCollection 2017 Mar-Apr.
4
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.同型神经元烟碱型乙酰胆碱受体的变构正位增效作用。
Br J Pharmacol. 2018 Jun;175(11):1805-1821. doi: 10.1111/bph.13745. Epub 2017 Mar 20.
5
The binding orientation of epibatidine at α7 nACh receptors.埃皮他啶在α7 烟碱型乙酰胆碱受体上的结合构象。
Neuropharmacology. 2017 Apr;116:421-428. doi: 10.1016/j.neuropharm.2017.01.008. Epub 2017 Jan 12.
6
Non-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacy.(α4β2)2α4烟碱型乙酰胆碱受体激动剂位点的非等效配体选择性:激动剂效力的关键决定因素。
J Biol Chem. 2014 Aug 1;289(31):21795-806. doi: 10.1074/jbc.M114.555136. Epub 2014 Jun 16.
7
Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.靶向α4β2-烟碱型乙酰胆碱受体的新型抗抑郁药的最新进展。
J Med Chem. 2014 Oct 23;57(20):8204-23. doi: 10.1021/jm401937a. Epub 2014 Jul 2.
8
Molecular recognition of the neurotransmitter acetylcholine by an acetylcholine binding protein reveals determinants of binding to nicotinic acetylcholine receptors.一种乙酰胆碱结合蛋白对神经递质乙酰胆碱的分子识别揭示了与烟碱型乙酰胆碱受体结合的决定因素。
PLoS One. 2014 Mar 17;9(3):e91232. doi: 10.1371/journal.pone.0091232. eCollection 2014.
9
Functional probes of drug-receptor interactions implicated by structural studies: Cys-loop receptors provide a fertile testing ground.结构研究表明的药物-受体相互作用的功能探针:半胱氨酸环受体提供了一个丰富的测试平台。
J Med Chem. 2014 Aug 14;57(15):6289-300. doi: 10.1021/jm500023m. Epub 2014 Mar 10.
10
Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: a computational and experimental study using epibatidine-related molecular probes.研究烟碱类药效团模型的氢键受体部位:使用与依匹巴林相关的分子探针的计算和实验研究。
J Comput Aided Mol Des. 2013 Nov;27(11):975-87. doi: 10.1007/s10822-013-9694-y. Epub 2013 Nov 26.

本文引用的文献

1
Variations in binding among several agonists at two stoichiometries of the neuronal, α4β2 nicotinic receptor.在神经元α4β2 烟碱型乙酰胆碱受体的两种计量结合中,几种激动剂结合的变化。
J Am Chem Soc. 2012 Jul 18;134(28):11474-80. doi: 10.1021/ja3011379. Epub 2012 Jul 9.
2
Structure and pharmacology of pentameric receptor channels: from bacteria to brain.五聚体受体通道的结构和药理学:从细菌到大脑。
Structure. 2012 Jun 6;20(6):941-56. doi: 10.1016/j.str.2012.05.003.
3
Nicotinic pharmacophore: the pyridine N of nicotine and carbonyl of acetylcholine hydrogen bond across a subunit interface to a backbone NH.烟碱药理学基团:尼古丁吡啶氮原子与乙酰胆碱羰基氢原子在亚基界面形成氢键,与骨架 NH 相互作用。
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13206-11. doi: 10.1073/pnas.1007140107. Epub 2010 Jun 28.
4
Long-range coupling in an allosteric receptor revealed by mutant cycle analysis.通过突变循环分析揭示的变构受体中的长程偶联
Biophys J. 2009 Apr 22;96(8):3168-78. doi: 10.1016/j.bpj.2008.12.3949.
5
Nicotine binding to brain receptors requires a strong cation-pi interaction.尼古丁与大脑受体的结合需要强烈的阳离子-π相互作用。
Nature. 2009 Mar 26;458(7237):534-7. doi: 10.1038/nature07768. Epub 2009 Mar 1.
6
An intersubunit hydrogen bond in the nicotinic acetylcholine receptor that contributes to channel gating.烟碱型乙酰胆碱受体中有助于通道门控的亚基间氢键。
J Biol Chem. 2008 Dec 19;283(51):35638-43. doi: 10.1074/jbc.M807226200. Epub 2008 Oct 24.
7
Cys-loop neuroreceptors: structure to the rescue?半胱氨酸环神经受体:结构能挽救局面吗?
Chem Rev. 2008 May;108(5):1642-53. doi: 10.1021/cr078207z. Epub 2008 May 1.
8
Structural characterization of agonist and antagonist-bound acetylcholine-binding protein from Aplysia californica.加州海兔中激动剂和拮抗剂结合的乙酰胆碱结合蛋白的结构表征。
J Mol Neurosci. 2006;30(1-2):101-2. doi: 10.1385/JMN:30:1:101.
9
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.海兔乙酰胆碱结合蛋白(AChBP)与烟碱型激动剂和拮抗剂复合物的结构揭示了独特的结合界面和构象。
EMBO J. 2005 Oct 19;24(20):3635-46. doi: 10.1038/sj.emboj.7600828. Epub 2005 Sep 29.
10
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.神经元烟碱型乙酰胆碱受体:结构揭示、靶点鉴定及治疗启示
J Med Chem. 2005 Jul 28;48(15):4705-45. doi: 10.1021/jm040219e.

与烟碱型乙酰胆碱受体互补亚基的结合相互作用。

Binding interactions with the complementary subunit of nicotinic receptors.

机构信息

Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.

出版信息

J Biol Chem. 2013 Mar 8;288(10):6991-7. doi: 10.1074/jbc.M112.439968. Epub 2013 Jan 24.

DOI:10.1074/jbc.M112.439968
PMID:23349463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3591609/
Abstract

The agonist-binding site of nicotinic acetylcholine receptors (nAChRs) spans an interface between two subunits of the pentameric receptor. The principal component of this binding site is contributed by an α subunit, and it binds the cationic moiety of the nicotinic pharmacophore. The other part of the pharmacophore, a hydrogen bond acceptor, has recently been shown to bind to the complementary non-α subunit via the backbone NH of a conserved Leu. This interaction was predicted by studies of ACh-binding proteins and confirmed by functional studies of the neuronal (CNS) nAChR, α4β2. The ACh-binding protein structures further suggested that the hydrogen bond to the backbone NH is mediated by a water molecule and that a second hydrogen bonding interaction occurs between the water molecule and the backbone CO of a conserved Asn, also on the non-α subunit. Here, we provide new insights into the nature of the interactions between the hydrogen bond acceptor of nicotinic agonists and the complementary subunit backbone. We studied both the nAChR of the neuromuscular junction (muscle-type) and a neuronal subtype, (α4)2(β4)3. In the muscle-type receptor, both ACh and nicotine showed a strong interaction with the Leu NH, but the potent nicotine analog epibatidine did not. This interaction was much attenuated in the α4β4 receptor. Surprisingly, we found no evidence for a functionally significant interaction with the backbone carbonyl of the relevant Asn in either receptor with an array of agonists.

摘要

烟碱型乙酰胆碱受体(nAChRs)的激动剂结合位点跨越五聚体受体两个亚基之间的界面。该结合位点的主要成分由α亚基贡献,并结合烟碱药效团的阳离子部分。药效团的另一部分,氢键受体,最近被证明通过保守亮氨酸的骨架 NH 与互补非α亚基结合。这种相互作用是通过对 ACh 结合蛋白的研究预测的,并通过对神经元(CNS)nAChR,α4β2 的功能研究得到证实。ACh 结合蛋白结构进一步表明,与骨架 NH 的氢键由水分子介导,并且水分子与另一个保守天冬酰胺的骨架 CO 之间发生第二氢键相互作用,该天冬酰胺也位于非α亚基上。在这里,我们提供了对烟碱激动剂的氢键受体与互补亚基骨架之间相互作用性质的新见解。我们研究了神经肌肉接头(肌肉型)和神经元亚型(α4)2(β4)3 的 nAChR。在肌肉型受体中,ACh 和尼古丁都与亮氨酸 NH 表现出强烈的相互作用,但强尼古丁类似物 epibatidine 则没有。这种相互作用在α4β4 受体中大大减弱。令人惊讶的是,我们发现与两种受体中相关天冬酰胺的骨架羰基没有证据表明与一系列激动剂有功能上重要的相互作用。